Saudi drug authority assessing new batch of COVID-19 vaccines for approval

05/04/2021 Argaam

Logo of Saudi Food and Drug Authority


Saudi Food and Drug Authority (SFDA) announced that a new batch of COVID-19 vaccines was received and is currently being studied and assessed in order to be approved soon, Al-Arabiya website reported.

The drug authority approved in December 2020 the registration of the Pfizer-BioNTech COVID-19 vaccine in the Kingdom, followed by the AstraZeneca vaccine last February.

Meanwhile, the Ministry of Health latest data showed that a total of 5.03 million doses of COVID-19 vaccines had been administered so far in the Kingdom.


News

Prices

Aramco IPONew

Sectors

Companies

Financial Data

Financial Ratios

Analysts

IPOs

Economy

Mutual Funds

Projects

Interactive Charts